These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 37443671)

  • 1. Could Endothelin-1 Be a Promising Neurohormonal Biomarker in Acute Heart Failure?
    Dmour BA; Costache AD; Dmour A; Huzum B; Duca ȘT; Chetran A; Miftode RȘ; Afrăsânie I; Tuchiluș C; Cianga CM; Botnariu G; Șerban LI; Ciocoiu M; Bădescu CM; Costache II
    Diagnostics (Basel); 2023 Jul; 13(13):. PubMed ID: 37443671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-converting enzyme inhibition in the rat model of acute heart failure: heart function and neurohormonal activation.
    Rufanova VA; Pozdnev VF; Kalenikova EI; Postnikov AB; Storozhilova AN; Masenko VP; Gomazkov OA; Medvedev OS; Medvedeva NA
    Exp Biol Med (Maywood); 2009 Oct; 234(10):1201-11. PubMed ID: 19596829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute heart failure: More questions than answers.
    Tomasoni D; Lombardi CM; Sbolli M; Cotter G; Metra M
    Prog Cardiovasc Dis; 2020; 63(5):599-606. PubMed ID: 32283133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically Relevant Biomarkers in Acute Heart Failure: An Update.
    Mukherji A; Ansari U; Borggrefe M; Akin I; Behnes M
    Curr Pharm Biotechnol; 2017; 18(6):482-490. PubMed ID: 28641514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurohormonal activation in acute heart failure: results from VERITAS.
    Milo-Cotter O; Cotter-Davison B; Lombardi C; Sun H; Bettari L; Bugatti S; Rund M; Metra M; Kaluski E; Kobrin I; Frey A; Rainisio M; McMurray JJ; Teerlink JR; Cotter-Davison G
    Cardiology; 2011; 119(2):96-105. PubMed ID: 21912122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of acute heart failure prognosis: the promising role of prognostic models and biomarkers.
    Kadoglou NPE; Parissis J; Karavidas A; Kanonidis I; Trivella M
    Heart Fail Rev; 2022 Mar; 27(2):655-663. PubMed ID: 34036472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach to treatment of acute heart failure.
    Goldsmith SR
    J Cardiol; 2016 May; 67(5):395-8. PubMed ID: 26946929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of FKBP12.6 and SERCA2a contributes to acute heart failure in septic shock and is related to an up-regulated endothelin signalling pathway.
    He HB; Yu F; Dai DZ; Dai Y
    J Pharm Pharmacol; 2007 Jul; 59(7):977-84. PubMed ID: 17637193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of neurohormonal activation.
    Pool PE
    Clin Ther; 1997; 19 Suppl A():53-73. PubMed ID: 9385505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology and clinical evaluation of acute heart failure.
    Mentz RJ; O'Connor CM
    Nat Rev Cardiol; 2016 Jan; 13(1):28-35. PubMed ID: 26370473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelitis profile in acute heart failure and cardiogenic shock patients: Endocan as a potential novel biomarker and putative therapeutic target.
    Reina-Couto M; Silva-Pereira C; Pereira-Terra P; Quelhas-Santos J; Bessa J; Serrão P; Afonso J; Martins S; Dias CC; Morato M; Guimarães JT; Roncon-Albuquerque R; Paiva JA; Albino-Teixeira A; Sousa T
    Front Physiol; 2022; 13():965611. PubMed ID: 36035482
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased mortality after an acute heart failure episode: new pathophysiological insights from the RELAX-AHF study and beyond.
    Cotter G; Milo O; Davison BA
    Curr Heart Fail Rep; 2014 Mar; 11(1):19-30. PubMed ID: 24363020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 9-Year Trend in the Management of Acute Heart Failure in Japan: A Report From the National Consortium of Acute Heart Failure Registries.
    Shiraishi Y; Kohsaka S; Sato N; Takano T; Kitai T; Yoshikawa T; Matsue Y
    J Am Heart Assoc; 2018 Sep; 7(18):e008687. PubMed ID: 30371201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurohormonal Imbalance: A Neglected Problem-And Potential Therapeutic Target-In Acute Heart Failure.
    Goldsmith SR; Bart BA; Pin A IL
    Curr Probl Cardiol; 2018 Jul; 43(7):294-304. PubMed ID: 29310997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and implications of endothelial dysfunction in congestive heart failure.
    Katz SD
    Curr Opin Cardiol; 1997 May; 12(3):259-64. PubMed ID: 9243083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in Acute Heart Failure: Diagnosis, Prognosis, and Treatment.
    Wettersten N
    Int J Heart Fail; 2021 Apr; 3(2):81-105. PubMed ID: 36262882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and therapeutic potential of the endothelin system in patients with chronic heart failure.
    Krum H; Denver R; Tzanidis A; Martin P
    Heart Fail Rev; 2001 Dec; 6(4):341-52. PubMed ID: 11447309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical management of acute heart failure.
    Kamran H; Tang WHW
    Fac Rev; 2021; 10():82. PubMed ID: 35028647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT).
    Masson S; Latini R; Anand IS; Barlera S; Judd D; Salio M; Perticone F; Perini G; Tognoni G; Cohn JN;
    J Card Fail; 2006 Jun; 12(5):375-80. PubMed ID: 16762801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.
    Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T
    Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.